Stanford University


Showing 11-20 of 66 Results

  • Nazish Sayed MD, PhD

    Nazish Sayed MD, PhD

    Associate Professor (Research) of Surgery (Vascular Surgery)

    Current Research and Scholarly InterestsThe Sayed Laboratory is focused on the development of novel technologies that drive innovation in regenerative medicine, disease modeling, and drug testing in vascular biology. The lab conducts translational research in vascular biology and aims to understand the role of the vasculature in the development of cardiac diseases, including those due to inherited genetic variants or environmental insults such as type 2 diabetes or hypertension. The lab employs the human induced pluripotent stem cell (iPSC) technology to generate patient-specific vascular cells (endothelial and vascular smooth muscle cells) as an alternative to animal models providing a human tissue surrogate for research that is scalable and sustainable. By employing this unique platform, the lab also investigates the role of chemotherapeutic agents (anti-cancer drugs) on the vasculature. Dr. Sayed’s lab has also established an endothelial regeneration program, where they leverage the innate immune system to regenerate endothelial cells from human fibroblasts.

    Work from the lab has led to seminal discoveries in the areas of 1) Nitric oxide (NO) biology, (2) vascular biology, (3) stem cell biology, (4) cardiovascular disease modeling (5) cardio-oncology.

  • Ingela Schnittger, MD

    Ingela Schnittger, MD

    Professor of Medicine (Cardiovascular)

    Current Research and Scholarly InterestsMy main research continues to be in the field of echocardiography. Several areas of research are currently being pursued.

  • Donald Schreiber

    Donald Schreiber

    Associate Professor of Emergency Medicine at the Stanford University Medical Center, Emeritus

    Current Research and Scholarly InterestsMy research group focuses on the diagnosis and treatment of cardiovascular emergencies including acute myocardial infarction, acute coronary syndrome and congestive heart failure. We have evaluated novel cardiac markers and point-of-care testing in clinical practice. Current projects also include the diagnosis and treatment of acute pulmonary embolism and deep venous thrombosis. Other interests include spinal cord injury, pneumonia and sepsis.

  • John S. Schroeder, MD

    John S. Schroeder, MD

    Professor (Clinical) of Medicine (Cardiovascular), Emeritus

    Current Research and Scholarly Interests1. Clinical Pharmocology of Cardiovascular Drugs
    (a) Calcium Channel Blockers
    (b) Agents for Heart Failure
    (c) Anti-atherosclerotic Effects of Cardiovascular Drugs, e.g. Calcium Channel Blockers

    2. Cardiac Transplantation/Congestive Heart Failure

    3. Coronary Artery Spasm

  • Vittorio Sebastiano

    Vittorio Sebastiano

    Associate Professor (Research) of Obstetrics and Gynecology (Reproductive, Perinatal & Stem Cell Biology Research)

    Current Research and Scholarly InterestsThe thread of Ariadne that connects germ cells, preimplatation development and pluripotent stem cells is the focus of my research, with a specific interest in human development. My long-term goals are: 1. Understanding the biology of germ cells and and their ability to sustain early preimplantation development; 2. Understanding the mechanisms that regulate very early cell fate decisions in human embryos; 3. Understanding the biology of derivation and maintenance of Pluripotent Stem Cells

  • George Segall

    George Segall

    Professor of Radiology, Emeritus

    Current Research and Scholarly InterestsScintigraphic evaluation of coronary blood flow and myocardial function using single photon emission computed tomography (SPECT) and positron emission tomography (PET). Tumor imaging and characterization of pulmonary nodules with PET/CT.

  • Zachary M. Sellers, MD, PhD

    Zachary M. Sellers, MD, PhD

    Adjunct Professor, Pediatrics - Gastroenterology

    BioDr. Sellers is a pediatric physician-scientist and research and clinical development consultant. As a pediatric gastroenterologist and ion channel physiologist, Dr. Sellers' work in academia and pharma over the last 20 years has focused on improving the lives of individuals with complex and rare diseases through providing cutting-edge clinical care and advancing research and drug development. Dr. Sellers previously led a basic and translational research laboratory at Stanford, focused on epithelial ion transport and acid-base regulation using a variety of human and animal models. He is a firm believer in the exponential impact of team science and is adept working in multi-disciplinary and cross-functional teams. He seeks out strategic partnerships and opportunities that can leverage his expertise and leadership to advance innovative therapies for areas of high unmet need and to support the development of the next generation of physician-scientists. Dr. Sellers received his BS (Animal Physiology and Neuroscience) and BA (Japanese Studies) from the University of California. San Diego, his MD and PhD (Molecular and Integrative Physiology) from the University of Illinois at Urbana-Champaign, and was trained in Pediatrics and Pediatric Gastroenterology, Hepatology, and Nutrition at Stanford, where he was previously a faculty member and attending physician. He held multiple leadership positions at Stanford, including Associate Chief of Research in Gastroenterology, Director of the Stanford Children's Pancreas Program, Lead Gastroenterologist for the CF Program, Director of the CFTR Phenotyping and Theratyping Program, and Physician-Scientist Advisor for the Pediatrics Residency Program.